Miracor Medical
Belgium - Awans
Medical DevicesFocus: Devices for Heart Disease
Miracor Medical is a life sciences company focused on Devices for Heart Disease.
CardiovascularMetabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Clinical Trials (1)
NCT04566289Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance
N/APiCSO
STEMIClinical Trials (1)
NCT03625869Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction
N/AClinical Trials (1)
NCT01493037PICSO in Patients With STEMI Treated by Primary Percutaneous Coronary Intervention
N/AClinical Trials (1)
NCT03473015Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion
N/APiCSO Impulse System
STEMI - ST Elevation Myocardial InfarctionClinical Trials (1)
NCT04958421A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction.
N/APiCSO Impulse System
STEMI - ST Elevation Myocardial InfarctionClinical Trials (1)
NCT05497011A Study to Evaluate the Safety and Efficacy of PiCSO in Anterior STEMI Patients
N/AN/A
Clinical Trials (1)
NCT02197325PiCSO in ACS Study
N/APiCSO Impulse System
Anterior Myocardial InfarctionClinical Trials (1)
NCT05644925Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL
N/APICSO
Stable AnginaClinical Trials (1)
NCT01308125Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention
Phase 2Phase 2
Clinical Trials (1)
NCT04032925The Pressure-controlled Intermittent Coronary Sinus Occlusion on VentrIcular PERformance Study
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 10 clinical trials
Visa Sponsorship
H-1B Petitions (FY2023)
0
Approved
1
Denied
0%
Rate
Source: USCIS H-1B Employer Data Hub